2 terminated, 1 suspended. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 1, Terminated 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow SonALAsense, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Recurrent GBM | Phase 1 / Phase 2 | Terminated | SonALAsense, Inc. | 8 | 2023-02-06 | 2024-07-26 |
| A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma | Phase 2 | Suspended | SonALAsense, Inc. | 15 | 2022-08-12 | 2024-09-19 |
| Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS), MR-Guided Focused Ultrasound device (MRgFUS) - High Grade Glioma | Early Phase 1 | Terminated | Nader Sanai | 10 | 2021-03-15 | 2026-05-14 |
Diffuse Intrinsic Pontine Glioma (1) · Glioblastoma (1) · Glioma (1)
United States (3)
Corina Andresen, MD (2) · Nader Sanai, MD (1)
R44CA261516 (1), R44CA275508 (1)